Cambridge Investment Research Advisors’s Conformis, Inc. Common Stock CFMS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,524	Closed	-$7K	–	3264
2022 Q3	$7K	Hold	1,524	–	–	﹤0.01%	3033
2022 Q2	$13K	Hold	1,524	–	–	﹤0.01%	3014
2022 Q1	$24K	Sell	1,524 -4	-0.3%	-$66	﹤0.01%	3115
2021 Q4	$29K	Buy	1,528 +147	+11%	+$3.77K	﹤0.01%	3126
2021 Q3	$46K	Buy	1,381 +160	+13%	+$5.64K	﹤0.01%	3030
2021 Q2	$35K	Buy	+1,221	New	+$28.8K	﹤0.01%	3044

Other funds holding CFMS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWE

Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cambridge Investment Research Advisors's CFMS Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Conformis, Inc. Common Stock (CFMS) in Q4 2022, closing a stake of 1,524 shares — an estimated $7K sold.

Cambridge Investment Research Advisors first reported a position in CFMS in Q2 2021 and held it in 6 quarters. The position peaked at $46K in Q3 2021. 35 funds tracked by Wall St. Rank hold CFMS as of Q4 2022.

Cambridge Investment Research Advisors reported no remaining Conformis, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 1,524 Conformis, Inc. Common Stock shares in Q4 2022, an estimated $7K.
Cambridge Investment Research Advisors first reported a position in Conformis, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Cambridge Investment Research Advisors's Conformis, Inc. Common Stock position peaked at $46K in Q3 2021.
35 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.